News

Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the 'Company”), a clinical stage pharmaceutical company, today announced ...
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...
This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial Coll ...
The CBI is calling for bold reforms including the removal of stamp duty on share purchases - a 0.5% tax that only applies to ...